VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 588 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2015. The put-call ratio across all filers is 2.30 and the average weighting 1.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $7,536,000 | +21.9% | 306,966 | 0.0% | 0.74% | +12.9% |
Q2 2016 | $6,182,000 | -23.8% | 306,966 | -0.6% | 0.65% | -19.4% |
Q1 2016 | $8,118,000 | -93.0% | 308,666 | -72.8% | 0.81% | -90.6% |
Q4 2015 | $115,530,000 | -53.0% | 1,136,554 | -17.5% | 8.56% | -36.6% |
Q3 2015 | $245,827,000 | -18.7% | 1,378,108 | +1.3% | 13.50% | -12.2% |
Q2 2015 | $302,291,000 | +69.5% | 1,360,752 | +51.5% | 15.37% | +39.2% |
Q1 2015 | $178,356,000 | +40.0% | 897,976 | +0.8% | 11.04% | +22.4% |
Q4 2014 | $127,429,000 | -2.5% | 890,426 | 0.0% | 9.02% | -6.6% |
Q3 2014 | $130,670,000 | +20.2% | 890,426 | +3.3% | 9.66% | +7.7% |
Q2 2014 | $108,745,000 | +8.0% | 862,236 | +24.4% | 8.97% | +10.8% |
Q1 2014 | $100,703,000 | +23.7% | 693,381 | 0.0% | 8.09% | +16.0% |
Q4 2013 | $81,403,000 | +15.0% | 693,381 | +2.2% | 6.98% | -7.3% |
Q3 2013 | $70,811,000 | +112.9% | 678,719 | +75.7% | 7.53% | +84.2% |
Q2 2013 | $33,253,000 | – | 386,300 | – | 4.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACCIPITER CAPITAL MANAGEMENT, LLC | 2,106,379 | $55,398,000 | 31.67% |
Claren Road Asset Management, LLC | 80,000 | $2,820,000 | 24.27% |
Okumus Fund Management Ltd. | 3,722,464 | $97,901,000 | 15.82% |
Wingspan Investment Management, LP | 852,900 | $22,431,000 | 12.66% |
FARLEY CAPITAL L.P. | 307,458 | $8,086,000 | 11.46% |
Chou Associates Management | 976,843 | $25,725,000 | 8.35% |
Wingspan Investment Management, LP | 550,700 | $14,483,000 | 8.17% |
HAP Trading, LLC | 4,043,900 | $109,610,000 | 8.00% |
LeVasseur Capital Partners LLC | 128,269 | $3,373,000 | 6.97% |
Pershing Square Capital Management | 21,591,122 | $567,847,000 | 6.41% |